BridgeMD
New treatment option for Rhegmatogenous Retinal Detachment
Official title hAM for Inferior RRD
ClinicalTrials.gov ID: NCT07081945
What this study is testing
- What it's testing
- The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- people having given free and informed consent to take part in the study.
- people between 18 and 70 years old.
- people suffering RRD (both primary and recurrent RRDs) with at least one of these conditions:
- inferior retinal breaks between 4- and 8-o'clock within the detached area regardless of PVR grade;
- requiring retinotomy inferiorly between 4- and 8-o'clock (due to severe inferior PVR or inferior retinal shortening).
You likely can't join if
- people with RRD with only anterior retina breaks or dialysis and meet the indications for scleral buckling surgery.
- people with RRD whose retinal breaks located between the 4- and 8-o'clock positions and are not involved in the detached area.
- people with pre-existing serious eye diseases (corneal ulcers, glaucoma, uveitis, etc).
- History of epilepsy or serious psychiatric diseases.
- Other conditions that the researcher found improper to be included into this study.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.